Agency Forms Undergoing Paperwork Reduction Act Review, 38599-38600 [E7-13605]
Download as PDF
38599
Federal Register / Vol. 72, No. 134 / Friday, July 13, 2007 / Notices
these activities elicit the desired effects
or impact.
ATSDR is requesting a reinstatement
with minor changes for the following
customer satisfaction surveys:
• ATSDR Web Site User Satisfaction
Survey (WSUS)
• Toxicological Profiles User
Satisfaction Survey (TPUS)
• ToxFAQsTM User Satisfaction
Survey (TFUS)
• Public Health Statements User
Satisfaction Survey (PHSUS)
• Toxicology Curriculum for
Communities Training Manual
User Satisfaction Survey (TCCUS)
• ToxProfilesTM CD–ROM User
Satisfaction Survey (TP–CDUS)
The results of this project will ensure
that these audiences will continue to
find our knowledge products and
informational pieces easy to access,
clear, informative and useful.
Specifically, this project will continue
to examine whether current and future
informational updates are presented in
an appropriate technological format and
whether they meet the needs, wants,
and preferences of visitors to the
ATSDR Web site. The survey questions
have been held to the absolute
minimum required for the use of the
data.
This extension request is for a threeyear period. There are no costs to the
respondents other than their time. The
total estimated annualized burden hours
are 166.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
ATSDR Web site Visitors ................................
WSUS .............................................................
TPUS ..............................................................
TFUS ..............................................................
PHSUS ...........................................................
TCCUS ...........................................................
TP–CDUS .......................................................
Dated: July 9, 2007.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E7–13597 Filed 7–12–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
1000
300
300
100
160
140
comments should be received within 30
days of this notice.
Proposed Project
CDC Model Performance Evaluation
Program (MPEP) (0920–0274)—
Revision—National Center for
Preparedness, Detection, and Control of
Infectious Diseases (proposed)
(NCPDCID), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
[30Day–07–0274]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an
e-mail to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
Number of
responses per
respondent
CDC is requesting OMB approval of a
revision to its data collection, the CDC
Model Performance Evaluation Program
(MPEP). CDC originally implemented
MPEP in 1986 to evaluate the
performance of laboratories conducting
testing to detect human
immunodeficiency virus type 1 (HIV–1)
antibody (Ab). CDC is requesting a 3year approval for this data collection.
In this program, respondents receive 2
shipments of specimens per year.
Respondents test the specimens in their
laboratory/testing site and report their
results either using a report booklet or
on-line. CDC provides the respondent
with a report containing the analysis of
the laboratory test results reported to
CDC. Participation in this program is
1
1
1
1
1
1
Average burden
per response
(in hours)
5/60
5/60
5/60
5/60
5/60
5/60
voluntary and provides the respondents
an opportunity to (1) assure accurate
tests are being provided by the
laboratory/testing site through external
quality assessment; (2) improve testing
quality through self-evaluation in a nonregulatory environment; (3) test well
characterized samples from a source
outside the test kit manufacturer; (4)
discover potential testing problems so
that procedures can be adjusted to
eliminate them; (5) compare of testing
results with others at a national and
international level; and (6) consult with
CDC staff to discuss testing issues.
In this request, CDC proposes to make
the following revisions to the currently
approved data collection:
• Addition of a Name and Address
change form to report changes for the
MPEP manager and coordinator at the
respondent laboratory;
• Inclusion of additional test kit
manufacturers approved by the FDA
since previous OMB approval; and
• Elimination of reporting HIV–1
RNA Viral Load and CD4+ T-cell
determinations.
There are no costs to the respondents
other than their time to complete the
survey. The total estimated annualized
burden hours are 257.
pwalker on PROD1PC71 with NOTICES
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Respondents
New Enrollees ........................................................................................................................
Laboratory Change Form ......................................................................................................
VerDate Aug<31>2005
19:05 Jul 12, 2007
Jkt 211001
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
E:\FR\FM\13JYN1.SGM
100
20
13JYN1
Number of
responses per
respondent
1
1
Average burden
per response
(in hours)
3/60
3/60
38600
Federal Register / Vol. 72, No. 134 / Friday, July 13, 2007 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents
Respondents
Laboratory Test Result Form .................................................................................................
Dated: July 9, 2007.
Maryam Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E7–13605 Filed 7–12–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Childhood
Lead Poisoning Prevention (ACCLPP),
National Center for Environmental
Health (NCEH)
pwalker on PROD1PC71 with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting of the
aforementioned committee:
Times and Dates:
8:30 a.m.–5 p.m., September 18, 2007.
8:30 a.m.–12:30 p.m., September 19, 2007.
Place: Radisson Plaza Hotel Minneapolis,
35 South 7th Street, Minneapolis, MN 55402,
Telephone: (612) 339–4900.
Open to the public, limited only by the
space available. The meeting room
accommodates approximately 75 people.
Purpose: The Committee provides advice
and guidance to the Secretary; the Assistant
Secretary for Health; and the Director, CDC,
regarding new scientific knowledge and
technological developments and their
practical implications for childhood lead
poisoning prevention efforts. The Committee
also reviews and reports regularly on
childhood lead poisoning prevention
practices and recommends improvements in
national childhood lead poisoning
prevention efforts.
Matters To Be Discussed: The meeting will
include discussion on the potential
approaches to strengthen existing strategies
to achieve the Healthy People 2010 goal of
eliminating Elevated Blood Lead Levels as a
Public Health Problem in the United States
by 2010, the development of a prevention
based research agenda, and the study designs
related to adverse effects from Blood Lead
Levels (BLLs) < 10 µg/dl; and updates on the
school performance and concurrent BLLs.
Agenda items are subject to change as
priorities dictate.
Opportunities will be provided during the
meeting for oral comments. Depending on the
time available and the number of requests, it
may be necessary to limit the time of each
presenter.
VerDate Aug<31>2005
19:05 Jul 12, 2007
Jkt 211001
Contact Person for More Information:
Claudine Johnson, Clerk, Lead Poisoning
Prevention Branch, Division of
Environmental Emergency Health Services,
NCEH, CDC, 4770 Buford Hwy, NE., Mailstop
F–40, Atlanta, GA 30341, Telephone (770)
488–3629, Fax (770) 488–3635.
The Director, Management Analysis and
Services Office has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: July 6, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–13596 Filed 7–12–07; 8:45 am]
BILLING CODE 4163–18–P
Number of
responses per
respondent
754
Average burden
per response
(in hours)
2
10/60
evaluation of research grant applications in
response to RFA DP07–707, ‘‘Racial and
Ethnic Approaches to Community Health
Across the United States (REACH US).’’
For Further Information Contact: Thijuanie
Lockhart, Program & Management Analyst,
CDC, 4770 Buford Highway, NE., Mail Stop
K–30, Atlanta, GA 30341, Telephone (404)
488–5303.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: July 9, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–13602 Filed 7–12–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Racial and Ethnic
Approaches to Community Health
Across the United States (REACH US),
Request for Applications (RFA) DP07–
707
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Public Law 92–463), the Centers for
Disease Control and Prevention (CDC)
announces a meeting of the
aforementioned Special Emphasis
Panel.
Times and Dates: 3 p.m.–8 p.m., July 31,
2007 (Closed), 8 a.m.–5 p.m., August 1, 2007
(Closed), 8 a.m.–5 p.m., August 2, 2007
(Closed), 3 p.m.–8 p.m., August 6, 2007
(Closed), 8 a.m.–5 p.m., August 7, 2007
(Closed), 8 a.m.–5 p.m., August 8, 2007
(Closed), 8 a.m.–5 p.m., August 9, 2007
(Closed).
Place: Sheraton Gateway Hotel Atlanta
Airport, 1900 Sullivan Road, Atlanta, GA
30337, Telephone (800) 454–6835.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Pub. L. 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–67776, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 72 FR 35491–35492,
dated June 28, 2007) is amended to
reflect the establishment of the
Extramural Research Program Office
within the National Center for Chronic
Disease Prevention and Health
Promotion, Coordinating Center for
Health Promotion, Centers for Disease
Control and Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows: After the functional statement
for the Program Services Branch
(CUC13), Office of the Director (CUC1),
National Center for Chronic Disease
Prevention and Health Promotion
(CUC), insert the following:
Extramural Research Program Office
(CUC18). The Extramural Research
Program Office (ERPO) plans, develops,
E:\FR\FM\13JYN1.SGM
13JYN1
Agencies
[Federal Register Volume 72, Number 134 (Friday, July 13, 2007)]
[Notices]
[Pages 38599-38600]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-13605]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-07-0274]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-6974.
Written comments should be received within 30 days of this notice.
Proposed Project
CDC Model Performance Evaluation Program (MPEP) (0920-0274)--
Revision--National Center for Preparedness, Detection, and Control of
Infectious Diseases (proposed) (NCPDCID), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
CDC is requesting OMB approval of a revision to its data
collection, the CDC Model Performance Evaluation Program (MPEP). CDC
originally implemented MPEP in 1986 to evaluate the performance of
laboratories conducting testing to detect human immunodeficiency virus
type 1 (HIV-1) antibody (Ab). CDC is requesting a 3-year approval for
this data collection.
In this program, respondents receive 2 shipments of specimens per
year. Respondents test the specimens in their laboratory/testing site
and report their results either using a report booklet or on-line. CDC
provides the respondent with a report containing the analysis of the
laboratory test results reported to CDC. Participation in this program
is voluntary and provides the respondents an opportunity to (1) assure
accurate tests are being provided by the laboratory/testing site
through external quality assessment; (2) improve testing quality
through self-evaluation in a non-regulatory environment; (3) test well
characterized samples from a source outside the test kit manufacturer;
(4) discover potential testing problems so that procedures can be
adjusted to eliminate them; (5) compare of testing results with others
at a national and international level; and (6) consult with CDC staff
to discuss testing issues.
In this request, CDC proposes to make the following revisions to
the currently approved data collection:
Addition of a Name and Address change form to report
changes for the MPEP manager and coordinator at the respondent
laboratory;
Inclusion of additional test kit manufacturers approved by
the FDA since previous OMB approval; and
Elimination of reporting HIV-1 RNA Viral Load and CD4+ T-
cell determinations.
There are no costs to the respondents other than their time to
complete the survey. The total estimated annualized burden hours are
257.
Total Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Respondents Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
New Enrollees................................................ 100 1 3/60
Laboratory Change Form....................................... 20 1 3/60
[[Page 38600]]
Laboratory Test Result Form.................................. 754 2 10/60
----------------------------------------------------------------------------------------------------------------
Dated: July 9, 2007.
Maryam Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E7-13605 Filed 7-12-07; 8:45 am]
BILLING CODE 4163-18-P